Indeed, peripherally synthesized ceramides, released into the bloodstream under conditions of obesity or T2D, can transit across the BBB, alter insulin signaling and induce insulin resistance in the brain [140]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.